We are live on !
Find out more
Cetera Trust Company Portfolio holdings
AUM
$199M
Turnover
3.39%
1-Year Est. Return
43.17%
This Fund
S&P 500
This Quarter Est. Return
+21.32%
1 Year Est. Return
+43.17%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$199M
AUM Growth
+$22.4M
(+13%)
Cap. Flow
-$2.38M
Cap. Flow % of AUM
Cap. Flow %
-1.19%
Top 10 Holdings %
Top 10 Hldgs %
32.54%
Holding
354
New
3
Increased
64
Reduced
36
Closed
9
Avg Time Held
2.3
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$446K |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$314K |
| 3 |
UnitedHealth
UNH
|
+$74.1K |
| 4 |
Elevance Health
ELV
|
+$59.3K |
| 5 |
Booking.com
BKNG
|
+$51.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$2.43M |
| 2 |
Lam Research
LRCX
|
+$288K |
| 3 |
Open Lending Corp
LPRO
|
+$147K |
| 4 |
Pultegroup
PHM
|
+$133K |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$103K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.24% |
| 2 | Financials | 16.68% |
| 3 | Healthcare | 13.4% |
| 4 | Industrials | 9.69% |
| 5 | Communication Services | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Lam Research
LRCX
$299B
| $15.5M | 7.79% |
35,810
-950
| -3% | -$288K |
2025 Q1
5 quarters
|
|
2
Apple
AAPL
$5.03T
| $11.4M | 5.73% |
39,492
-150
| -0.4% | -$42.9K |
2023 Q4
10 quarters
|
|
|
3
Alphabet (Google) Class A
GOOGL
$3.44T
| $5.87M | 2.94% |
16,423
-285
| -2% | -$103K |
2023 Q4
10 quarters
|
|
4
JPMorgan Chase
JPM
$895B
| $5.23M | 2.62% |
15,969
-125
| -0.8% | -$38.8K |
2023 Q4
10 quarters
|
|
5
Microsoft
MSFT
$3.88T
| $4.91M | 2.47% |
13,170
| – | – |
2023 Q4
10 quarters
|
|
6
Amazon
AMZN
$2.59T
| $4.67M | 2.34% |
19,607
-175
| -0.9% | -$43.9K |
2023 Q4
10 quarters
|
|
7
McKesson
MCK
$116B
| $4.53M | 2.27% |
5,995
-30
| -0.5% | -$23.8K |
2023 Q4
10 quarters
|
|
8
Walmart Inc
WMT
$980B
| $4.52M | 2.27% |
39,885
-430
| -1% | -$53.4K |
2023 Q4
10 quarters
|
|
9
Broadcom
AVGO
$1.56T
| $4.51M | 2.26% |
11,945
-250
| -2% | -$100K |
2023 Q4
10 quarters
|
|
10
Bank of America
BAC
$346B
| $3.67M | 1.84% |
64,468
+325
| +0.5% | +$17.3K |
2023 Q4
10 quarters
|
|
11
RTX Corp
RTX
$270B
| $3.43M | 1.72% |
18,102
| – | – |
2023 Q4
10 quarters
|
|
12
Visa
V
$773B
| $3.31M | 1.66% |
9,645
+45
| +0.5% | +$14.4K |
2023 Q4
10 quarters
|
|
13
Amgen
AMGN
$252B
| $3.25M | 1.63% |
8,983
-50
| -0.6% | -$17.1K |
2023 Q4
10 quarters
|
|
14
Delta Air Lines
DAL
$52.7B
| $3.18M | 1.6% |
33,954
-500
| -1% | -$37.7K |
2023 Q4
10 quarters
|
|
15
Alphabet (Google) Class C
GOOG
$3.42T
| $2.84M | 1.43% |
8,040
-225
| -3% | -$80.4K |
2023 Q4
10 quarters
|
|
16
General Motors
GM
$74.2B
| $2.79M | 1.4% |
36,134
+50
| +0.1% | +$3.93K |
2023 Q4
10 quarters
|
|
17
Blackrock
BLK
$177B
| $2.77M | 1.39% |
2,877
-15
| -0.5% | -$15.5K |
2025 Q1
5 quarters
|
|
18
Avantis International Equity ETF
AVDE
$19.3B
| $2.63M | 1.32% |
29,437
| – | – |
2023 Q4
10 quarters
|
|
19
Charles Schwab
SCHW
$152B
| $2.52M | 1.27% |
27,330
-25
| -0.1% | -$2.28K |
2023 Q4
10 quarters
|
|
20
Coca-Cola
KO
$405B
| $2.51M | 1.26% |
30,896
+300
| +1% | +$23.7K |
2023 Q4
10 quarters
|
|
21
Eli Lilly
LLY
$1.26T
| $2.5M | 1.26% |
2,087
| – | – |
2023 Q4
10 quarters
|
|
22
FedEx
FDX
$73.4B
| $2.37M | 1.19% |
7,560
-85
| -1% | -$30.9K |
2023 Q4
10 quarters
|
|
23
MetLife
MET
$63.6B
| $2.29M | 1.15% |
27,010
-150
| -0.6% | -$12.1K |
2023 Q4
10 quarters
|
|
24
Thermo Fisher Scientific
TMO
$258B
| $2.26M | 1.13% |
4,511
-80
| -2% | -$38.4K |
2023 Q4
10 quarters
|
|
25
Microchip Technology
MCHP
$42B
| $2.04M | 1.02% |
22,394
-350
| -2% | -$31.2K |
2023 Q4
10 quarters
|
|
Similar funds
SFC
DT
Cetera Trust Company's Q2 2026 Portfolio in Review
As of Q2 2026, Cetera Trust Company held 354 positions worth $199M, up 13% from $177M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 3.4%. Cetera Trust Company opened 3 new positions and exited 9, leaving the 354-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Cetera Trust Company's largest Q2 2026 buy was AstraZeneca: 2,369 shares worth $449K.
- Cetera Trust Company added most to UnitedHealth in Q2 2026, an estimated $74.1K increase.
- Cetera Trust Company's biggest Q2 2026 reduction was Lam Research, cutting an estimated $288K.
- Cetera Trust Company fully exited Honeywell in Q2 2026, selling an estimated $2.43M.
- Cetera Trust Company's ten largest holdings make up 33% of its $199M portfolio in Q2 2026.
- Cetera Trust Company opened 3 new positions and closed 9 in Q2 2026.
- Cetera Trust Company's portfolio value rose 13% quarter-over-quarter to $199M.
Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.